Cme Group INC 8-K filings

NASDAQ

7 Mar 2024

CME

8-K: CME Group Amends Stock Plan to Align with Shareholder Preferences

CME Group has amended its Omnibus Stock Plan to include double-trigger change of control vesting provisions, aligning with market practices and shareholder preferences.

NASDAQ

14 Feb 2024

CME

Cme Group INC

8-K: CME Group Reports Record 2023 Results Driven by Interest Rate Products

CME Group announced record full-year 2023 financial results, driven by strong performance in interest rate products and record average daily volume.